Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Find work from home jobs that require no experience. These opportunities can help you earn money while enjoying flexibility.
13,357 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A four-year vulnerability found by Anthropic's Claude AI triggered a rapid sell-off in Zcash, slashing market value b...
Synopsys, a leader in chip design software, trades below its 52-week high even as revenue grows, highlighting investo...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
April data show the fed's favored inflation gauge rose modestly, keeping inflation well above the 2% target. Analysts...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
A 56-year-old hospital administrator faces a potential half-million-dollar federal tax bill on an inherited $1.8 mill...
Rising tax considerations in 2026 are prompting investors to rethink where they hold SCHD. This article breaks down w...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
When executives cash out after a stock's triple-digit run, it can raise questions for investors. This guide explains ...
A niche corner of the tech market has seen attention turn toward optical component makers. This article explains why ...
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...